Global Pruritus Therapeutics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Pruritus Therapeutics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.

According to APO Research, The global Pruritus Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pruritus Therapeutics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pruritus Therapeutics, also provides the value of main regions and countries. Of the upcoming market potential for Pruritus Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pruritus Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pruritus Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Pruritus Therapeutics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Pruritus Therapeutics segment by Company

J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Pruritus Therapeutics segment by Type

Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Pruritus Therapeutics segment by Application

External Use
Oral
Injection
Pruritus Therapeutics segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Pruritus Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pruritus Therapeutics key companies, revenue, market share, and recent developments.
3. To split the Pruritus Therapeutics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pruritus Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pruritus Therapeutics significant trends, drivers, influence factors in global and regions.
6. To analyze Pruritus Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pruritus Therapeutics industry.
Chapter 3: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pruritus Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pruritus Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Pruritus Therapeutics Market Size, 2019 VS 2023 VS 2030
1.3 Global Pruritus Therapeutics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pruritus Therapeutics Market Dynamics
2.1 Pruritus Therapeutics Industry Trends
2.2 Pruritus Therapeutics Industry Drivers
2.3 Pruritus Therapeutics Industry Opportunities and Challenges
2.4 Pruritus Therapeutics Industry Restraints
3 Pruritus Therapeutics Market by Company
3.1 Global Pruritus Therapeutics Company Revenue Ranking in 2023
3.2 Global Pruritus Therapeutics Revenue by Company (2019-2024)
3.3 Global Pruritus Therapeutics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Pruritus Therapeutics Company Manufacturing Base & Headquarters
3.5 Global Pruritus Therapeutics Company, Product Type & Application
3.6 Global Pruritus Therapeutics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Pruritus Therapeutics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Pruritus Therapeutics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Pruritus Therapeutics Market by Type
4.1 Pruritus Therapeutics Type Introduction
4.1.1 Antihistamines
4.1.2 Corticosteroids
4.1.3 Calcineurin Inhibitors
4.1.4 Others
4.2 Global Pruritus Therapeutics Sales Value by Type
4.2.1 Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pruritus Therapeutics Sales Value by Type (2019-2030)
4.2.3 Global Pruritus Therapeutics Sales Value Share by Type (2019-2030)
5 Pruritus Therapeutics Market by Application
5.1 Pruritus Therapeutics Application Introduction
5.1.1 External Use
5.1.2 Oral
5.1.3 Injection
5.2 Global Pruritus Therapeutics Sales Value by Application
5.2.1 Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pruritus Therapeutics Sales Value by Application (2019-2030)
5.2.3 Global Pruritus Therapeutics Sales Value Share by Application (2019-2030)
6 Pruritus Therapeutics Market by Region
6.1 Global Pruritus Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Pruritus Therapeutics Sales Value by Region (2019-2030)
6.2.1 Global Pruritus Therapeutics Sales Value by Region: 2019-2024
6.2.2 Global Pruritus Therapeutics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Pruritus Therapeutics Sales Value (2019-2030)
6.3.2 North America Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pruritus Therapeutics Sales Value (2019-2030)
6.4.2 Europe Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Pruritus Therapeutics Sales Value (2019-2030)
6.5.2 Asia-Pacific Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Pruritus Therapeutics Sales Value (2019-2030)
6.6.2 Latin America Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Pruritus Therapeutics Sales Value (2019-2030)
6.7.2 Middle East & Africa Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
7 Pruritus Therapeutics Market by Country
7.1 Global Pruritus Therapeutics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Pruritus Therapeutics Sales Value by Country (2019-2030)
7.2.1 Global Pruritus Therapeutics Sales Value by Country (2019-2024)
7.2.2 Global Pruritus Therapeutics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.3.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.4.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.5.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.6.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.7.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.8.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.9.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.10.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.11.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.12.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.13.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.14.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.15.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.16.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.17.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.18.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.19.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.20.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.21.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 J&J
8.1.1 J&J Comapny Information
8.1.2 J&J Business Overview
8.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.1.4 J&J Pruritus Therapeutics Product Portfolio
8.1.5 J&J Recent Developments
8.2 Abbott
8.2.1 Abbott Comapny Information
8.2.2 Abbott Business Overview
8.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.2.4 Abbott Pruritus Therapeutics Product Portfolio
8.2.5 Abbott Recent Developments
8.3 Amgen
8.3.1 Amgen Comapny Information
8.3.2 Amgen Business Overview
8.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.3.4 Amgen Pruritus Therapeutics Product Portfolio
8.3.5 Amgen Recent Developments
8.4 LEO Pharma
8.4.1 LEO Pharma Comapny Information
8.4.2 LEO Pharma Business Overview
8.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
8.4.5 LEO Pharma Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.5.4 Novartis Pruritus Therapeutics Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Bayer
8.6.1 Bayer Comapny Information
8.6.2 Bayer Business Overview
8.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.6.4 Bayer Pruritus Therapeutics Product Portfolio
8.6.5 Bayer Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.7.4 Pfizer Pruritus Therapeutics Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 UCB Pharma
8.8.1 UCB Pharma Comapny Information
8.8.2 UCB Pharma Business Overview
8.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
8.8.5 UCB Pharma Recent Developments
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Comapny Information
8.9.2 GlaxoSmithKline Business Overview
8.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
8.9.5 GlaxoSmithKline Recent Developments
8.10 Galderma
8.10.1 Galderma Comapny Information
8.10.2 Galderma Business Overview
8.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.10.4 Galderma Pruritus Therapeutics Product Portfolio
8.10.5 Galderma Recent Developments
8.11 Huapont
8.11.1 Huapont Comapny Information
8.11.2 Huapont Business Overview
8.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.11.4 Huapont Pruritus Therapeutics Product Portfolio
8.11.5 Huapont Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings